BOT 2.90% 33.5¢ botanix pharmaceuticals ltd

If Japan is any indicator then it should scale pretty quick,...

  1. 320 Posts.
    lightbulb Created with Sketch. 41
    If Japan is any indicator then it should scale pretty quick, management know that first impressions are critical for a best in class product that cost a pretty penny, so they are taking their time to get an exposure to a limited number of first user experiences and making sure its perfect when the masses get it, they haven't decided to rush straight to market for quick cash because they have experience in product launches and know first time experiences matter.

    Neuren's product is expected to generate $340m-$370m USD this financial year, can you imagine if they were the main seller, it would be worth much more than their current $2b market value now if they weren't just getting a royalty from that amount. Bot has a similar opportunity to generate that much in revenue if it scales the same way as Japan, with a current market value of just over $600m it doesn't take much imagination of what it could be worth in the future.
    Last edited by silverblizzard888: Today, 07:54
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
33.5¢
Change
-0.010(2.90%)
Mkt cap ! $624.4M
Open High Low Value Volume
33.5¢ 33.5¢ 33.5¢ $17.34K 51.78K

Buyers (Bids)

No. Vol. Price($)
2 81284 33.5¢
 

Sellers (Offers)

Price($) Vol. No.
34.0¢ 53000 3
View Market Depth
Last trade - 10.00am 08/08/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.